𝔖 Bobbio Scriptorium
✦   LIBER   ✦

“Boost” of proton therapy helps reduce prostate cancer recurrence

✍ Scribed by Carrie Printz

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
905 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of prostate cancer recurrence
Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option
✍ Gregory W. Allen; Andrew R. Howard; David F Jarrard; Mark A. Ritter 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Depending on initial prognostic factors, an estimated 10%–60% of men who undergo definitive radiation therapy for prostate cancer may experience a biochemical recurrence. Even though hormonal therapy is standard for metastatic recurrences, no consensus exists on optimal salvage therapy

Expression of microRNA-221 is progressiv
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
✍ Martin Spahn; Susanne Kneitz; Claus-Jürgen Scholz; Nico Stenger; Thomas Rüdiger; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 435 KB

## Abstract Emerging evidence shows that microRNAs (miR) are involved in the pathogenesis of a variety of cancers, including prostate carcinoma (PCa). Little information is available regarding miR expression levels in lymph node metastasis of prostate cancer or the potential of miRs as prognostic m

Prediction of locally recurrent prostate
Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion-weighted MRI
✍ Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

## Abstract ## Purpose To prospectively evaluate the incremental value of diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps in addition to T2‐weighted imaging (T2WI) for predicting locally recurrent prostate cancer in patients with biochemical failure after radiation

Follow-up ProstaScint� scans verify dete
Follow-up ProstaScint� scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy
✍ Murphy, Gerald P.; Elgamal, Abdel-Aziz A.; Troychak, Michael J.; Kenny, Gerald M 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## BACKGROUND. A reliable imaging modality is required to uncover occult soft-tissue recurrence after failure of primary prostate cancer therapy. This retrospective study was done to evaluate the ability of the 111 Indium-labeled monoclonal antibody (ProstaScint) scan in detection of prostatic bed

Causes of death in men undergoing androg
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer
✍ Anthony V. D'Amico; Ming-Hui Chen; Andrew A. Renshaw; Marian Loffredo; Philip W. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. The authors estimated and characterized mortality after androgen suppression therapy (AST) use in men with newly diagnosed localized and recurrent prostate cancer. ## METHODS. The study cohorts comprised 102 men who were randomized to radiation therapy (RT) and AST and